Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel S Merseburger

Showing results (161-170 of 323) with videos related to

Pageof 33
Sort By:
World Journal of Urology|October 3, 2013
Age--an independent prognostic factor of clinical outcome in renal malignancies: results of a large study over two decadesMarie C Hupe, Axel S Merseburger, Vinata B Lokeshwar, et al.
Molecular Biology Reports|December 8, 2022
The alternative renin-angiotensin-system (RAS) signalling pathway in prostate cancer and its link to the current COVID-19 pandemicFabian Sehn, Hartwig Büttner, Beate Godau, et al.
Advances in Therapy|March 2, 2025
Cardiovascular Risks and Survival with Abiraterone vs Enzalutamide in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer in Germany: AVENGER StudyAxel S Merseburger, Eugen Dornstauder, Carsten-Henning Ohlmann, et al.
Urologia Internationalis|February 26, 2020
The Impact of Endourological Experience on Flexible Ureteroscopy Outcomes and Performance at Different Levels of Expertise: Retrospective Multifactorial AnalysisTomasz Ozimek, Mario W Kramer, Marie C Hupe, et al.
European Urology|October 30, 2010
Is there a need to further subclassify pT2 renal cell cancers as implemented by the revised 7th TNM version?Sandra Waalkes, Frank Becker, Andres J Schrader, et al.
European Urology|August 24, 2005
Cathepsin D expression in renal cell cancer-clinical implicationsAxel S Merseburger, Joerg Hennenlotter, Perikles Simon, et al.
Oncology Reports|June 21, 2006
Activation of the PKB/Akt pathway in histological benign prostatic tissue adjacent to the primary malignant lesionsAxel S Merseburger, Jörg Hennenlotter, Perikles Simon, et al.
BMC Cancer|April 24, 2013
Reduced mRNA expression level of corticotropin-releasing hormone-binding protein is associated with aggressive human kidney cancerHossein Tezval, Faranaz Atschekzei, Inga Peters, et al.
Rare Tumors|July 9, 2014
Synovial sarcoma of the kidney in a young patient with a review of the literatureMahmoud Abbas, Maximilian E Dämmrich, Peter Braubach, et al.
BJU International|February 1, 2012
GATA5 CpG island methylation in renal cell cancer: a potential biomarker for metastasis and disease progressionInga Peters, Hendrik Eggers, Faranaz Atschekzei, et al.
Pageof 33

Showing results (161-170 of 323) with videos related to

Sort By:
Pageof 33
World Journal of Urology|October 3, 2013
Age--an independent prognostic factor of clinical outcome in renal malignancies: results of a large study over two decadesMarie C Hupe, Axel S Merseburger, Vinata B Lokeshwar, et al.
Molecular Biology Reports|December 8, 2022
The alternative renin-angiotensin-system (RAS) signalling pathway in prostate cancer and its link to the current COVID-19 pandemicFabian Sehn, Hartwig Büttner, Beate Godau, et al.
Advances in Therapy|March 2, 2025
Cardiovascular Risks and Survival with Abiraterone vs Enzalutamide in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer in Germany: AVENGER StudyAxel S Merseburger, Eugen Dornstauder, Carsten-Henning Ohlmann, et al.
Urologia Internationalis|February 26, 2020
The Impact of Endourological Experience on Flexible Ureteroscopy Outcomes and Performance at Different Levels of Expertise: Retrospective Multifactorial AnalysisTomasz Ozimek, Mario W Kramer, Marie C Hupe, et al.
European Urology|October 30, 2010
Is there a need to further subclassify pT2 renal cell cancers as implemented by the revised 7th TNM version?Sandra Waalkes, Frank Becker, Andres J Schrader, et al.
European Urology|August 24, 2005
Cathepsin D expression in renal cell cancer-clinical implicationsAxel S Merseburger, Joerg Hennenlotter, Perikles Simon, et al.
Oncology Reports|June 21, 2006
Activation of the PKB/Akt pathway in histological benign prostatic tissue adjacent to the primary malignant lesionsAxel S Merseburger, Jörg Hennenlotter, Perikles Simon, et al.
BMC Cancer|April 24, 2013
Reduced mRNA expression level of corticotropin-releasing hormone-binding protein is associated with aggressive human kidney cancerHossein Tezval, Faranaz Atschekzei, Inga Peters, et al.
Rare Tumors|July 9, 2014
Synovial sarcoma of the kidney in a young patient with a review of the literatureMahmoud Abbas, Maximilian E Dämmrich, Peter Braubach, et al.
BJU International|February 1, 2012
GATA5 CpG island methylation in renal cell cancer: a potential biomarker for metastasis and disease progressionInga Peters, Hendrik Eggers, Faranaz Atschekzei, et al.
Pageof 33